| Thu, Jul 9, 2009 | | • | American Int'l Group, Novogen: Biggest Price Decliners (AIG, NVGN)
at The Wall Street Journal Online (Thu, Jul 9)
| | Wed, Jul 8, 2009 | | • | Steak N Shake, Novogen: Biggest Price Gainers (SNS, NVGN)
at The Wall Street Journal Online (Wed, Jul 8)
| | • | NVGN Small-Cap Leader Second Consecutive Day
SmallCapInvestor.com (Wed, Jul 8)
| | Tue, Jul 7, 2009 | | • | Ruby Tuesday, Novogen: Biggest Price Gainers (RT, NVGN)
at The Wall Street Journal Online (Tue, Jul 7)
| | • | Par Technology, Novogen: Biggest Price Gainers (PTC, NVGN)
at The Wall Street Journal Online (Tue, Jul 7)
| | • | Researchers Discover That Phenoxodiol Kills Rapidly Proliferating T-Cells
Marketwire (Tue, Jul 7)
| | Wed, Jun 17, 2009 | | • | Independent Data Monitoring Committee Reviews Marshall Edwards, Inc.'s Arrangements for Data Analysis of the Ovature Trial
Marketwire (Wed, Jun 17)
| | Tue, May 19, 2009 | | • | M/I Homes, Novogen: Biggest Price Decliners (MHO, NVGN)
at The Wall Street Journal Online (Tue, May 19)
| | Mon, May 18, 2009 | | • | Dillard's, Novogen: Biggest Price Gainers (DDS, NVGN)
at The Wall Street Journal Online (Mon, May 18)
| | • | ICICI Bank, Novogen: Biggest Price Gainers (IBN, NVGN)
at The Wall Street Journal Online (Mon, May 18)
| | • | Novogen Depository Receipt, Logility and OncoGenex Pharmaceuticals lead small-cap percentage gainers
SmallCapInvestor.com (Mon, May 18)
| | Mon, Apr 20, 2009 | | • | Novogen's NV-128 Targets the mTOR Pathway to Block Differentiation and Induce Cell Death in Ovarian Cancer Stem Cells
Marketwire (Mon, Apr 20)
| | • | Novogen's NV-128 Targets the mTOR Pathway to Block Differentiation and Induce Cell Death in Ovarian Cancer Stem Cells
Marketwire (Mon, Apr 20)
| | Tue, Apr 14, 2009 | | • | Marshall Edwards, Inc., to Undertake Analysis of Ovature Trial
Marketwire (Tue, Apr 14)
| | • | Marshall Edwards, Inc., to Undertake Analysis of Ovature Trial
Marketwire (Tue, Apr 14)
| | Mon, Mar 23, 2009 | | • | Board Changes at Novogen Limited Announced
Marketwire (Mon, Mar 23)
| | Thu, Mar 19, 2009 | | • | Biotech Analyst Joins Board of Directors of Marshall Edwards, Inc.
Marketwire (Thu, Mar 19)
| | Wed, Mar 18, 2009 | | • | Novogen's NV-128 Targets the mTOR Pathway to Induce Cell Death in Epithelial Ovarian Cancer Stem Cells
Marketwire (Wed, Mar 18)
| | • | Triphendiol Safety Data Clears the Way for Compound to Be Studied Further in the Treatment of Pancreatic Cancer
Marketwire (Wed, Mar 18)
| | Tue, Feb 24, 2009 | | • | Yale Researchers Present Results of Phase II Phenoxodiol Clinical Trial in Prostate Cancer Patients at ASCO 2009 Genitourinary Cancers Symposium
Marketwire (Tue, Feb 24)
|
Add NVGN News to My Yahoo!:
 
| |
|
0.45% Nasdaq 
0.20%
Headlines
